Saturday, December 21, 2024
12/21/2024
Program Director/Principal Investigator (Last, First, Middle): Galán, Jorge PROJECT SUMMARY: Many symbiotic or pathogenic bacteria have evolved complex specialized machines known as type III secretion systems (T3SS), which have the capacity to transfer multiple bacterially-encoded proteins into host eukaryotic cells. These machines are of great interest because they are central to the pathogenic or symbiotic relationships of the bacteria that encode them. Proteins delivered by these machines, collectively referred to as “effectors”, can modulate a great variety of eukaryotic cellular functions to shape the bacteria/host cell functional interphase. Through work supported by this Grant, we have been studying a T3SS from Salmonella enterica serovar Typhimurium (S. Typhimurium), encoded within its pathogenicity island 1 (SPI-1). This system mediates several phenotypes that are essential for virulence including bacterial entry into and survival within non-phagocytic cells, the induction of programmed cell death in macrophages, and the modulation of innate immune responses and inflammation in the intestinal tract. The central component of all T3SSs is the needle complex, a supramolecular structure which allows the translocation of proteins through the bacterial envelope during their journey to eukaryotic target cells. The needle complex works in association with other components such as the export apparatus, which mediates passage of the secreted proteins through the bacterial inner membrane, and the “sorting platform”, a cytoplasmic structure that establishes an order in the secretion process. Additional components regulate the function of this machine to ensure that it is activated and deployed at the appropriate time (i. e. upon contact with target cells). Energy to drive protein translocation and the unfolding of the protein substrates is derived from an associated ATPase as well as a proton gradient established by poorly understood mechanisms. This research project intends to investigate less understood aspects of type III protein secretion including the mechanisms of sensing, signal transduction, and activation of the type III secretion machine, the deployment of the T3SS translocon into the target eukaryotic cell membrane, the structure and function of the T3SS export apparatus, and the mechanisms of by which the T3SS recognizes its substrates. Accomplishing these objectives will not only enhance our understanding of Salmonella spp. pathogenesis but also our understanding of T3SSs in general. Since this system is central to the pathogenesis of many important pathogenic bacteria, these studies may provide the bases for the development of broadly applicable anti-infective strategies. RELEVANCE: Many important bacterial pathogens such as Salmonella, Yersinia, Shigella, E. coli, Pseudomonas aeruginosa, Burkhodleria spp., Chlamydia spp., and Bordetella pertussis possess specialized nanomachine known as the type III protein secretion system, which is essential for their ability to cause disease. This machine “injects” bacterial proteins into the cells of the host to alter cellular functions for the pathogen’s benefit. This project intends to study how this nanomachine works. The understanding of the mechanisms by which the type III secretion nanomachine works can lead to the development of broadly active anti infective strategies.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).